SCHEMBL7541733

SCHEMBL7541733

NC(=O)CC[C@H](N)C(=O)NCC(N)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BLM P54132 2/20 0.54
ALOX15 P16050 1/20 0.54
PMP22 Q01453 1/20 0.54
KMT2A Q03164 1/20 0.54
DPP4 P27487 2/20 0.51
DPP8 Q6V1X1 2/20 0.51
DPP9 Q86TI2 2/20 0.51
DPP7 Q9UHL4 2/20 0.39
PTGS1 P23219 1/20 0.37
GSTK1 Q9Y2Q3 1/20 0.37
RRM1 P23921 1/20 0.36
GRM8 O00222 1/20 0.35
GRM6 O15303 1/20 0.35
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GSR P00390 1/20 0.35
CYP1A2 P05177 1/20 0.35
GRIK1 P39086 1/20 0.35
GRM5 P41594 1/20 0.35
GRIA1 P42261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7541728 1.00 BLM (0.54) BLMALOX15PMP22KMT2ADPP4
SCHEMBL2483653 0.88 BLM (0.55) BLMALOX15PMP22KMT2ADPP4
SCHEMBL8505286 0.88 BLM (0.55) BLMALOX15PMP22KMT2ADPP4
SCHEMBL2483655 0.88 BLM (0.55) BLMALOX15PMP22KMT2ADPP4
SCHEMBL22479710 0.88 GRM8 (0.52) BLMALOX15PMP22KMT2ADPP4
SCHEMBL11957999 0.88 GRM8 (0.52) BLMALOX15PMP22KMT2ADPP4
SCHEMBL18175265 0.86 DPP4 (0.51) BLMALOX15PMP22KMT2ADPP4
SCHEMBL5016763 0.83 DPP4 (0.49) BLMALOX15PMP22KMT2ADPP4
SCHEMBL3681093 0.82 BLM (0.48) BLMALOX15PMP22KMT2ADPP4
SCHEMBL31475685 0.82 DPP4 (0.55) BLMALOX15PMP22KMT2ADPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1207897-A2 PHARMACEUTICAL COMPOSITIONS CONTAINING TRIPEPTIDES TRIPEP AB (SE) 2002-05-29 EP disclosed
EP-1206273-A2 PEPTIDES THAT BLOCK VIRAL INFECTIVITY AND METHODS OF USE THEREOF TRIPEP AB (SE) 2002-05-22 EP disclosed
WO-2001010457-A2 PHARMACEUTICAL COMPOSITIONS CONTAINING TRIPEPTIDES TRIPEP AB (SE) 2001-02-15 WO disclosed
WO-2001010456-A2 PEPTIDES THAT BLOCK VIRAL INFECTIVITY AND METHODS OF USE THEREOF TRIPEP AB (SE) 2001-02-15 WO disclosed